Eudaimonia Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,780
| Closed | -$369K | – | 406 |
|
|
2022
Q1 | $369K | Buy |
+6,780
| New | +$369K | 0.06% | 285 |
|
|
2021
Q3 | $291K | Buy |
6,092
+92
| +2% | +$4.4K | 0.05% | 313 |
|
|
2021
Q2 | $299K | Buy |
6,000
+1,782
| +42% | +$88.8K | 0.06% | 301 |
|
|
2021
Q1 | $188K | Sell |
4,218
-580
| -12% | -$25.9K | 0.04% | 342 |
|
|
2020
Q4 | $221K | Sell |
4,798
-37
| -0.8% | -$1.7K | 0.05% | 292 |
|
|
2020
Q3 | $227K | Sell |
4,835
-239
| -5% | -$11.2K | 0.06% | 262 |
|
|
2020
Q2 | $259K | Sell |
5,074
-213
| -4% | -$10.9K | 0.1% | 208 |
|
|
2020
Q1 | $250K | Buy |
5,287
+516
| +11% | +$24.4K | 0.11% | 190 |
|
|
2019
Q4 | $280K | Buy |
+4,771
| New | +$280K | 0.11% | 199 |
|